We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$128M
(+5.3%)
Cap. Flow
+$62.6M
Cap. Flow
% of AUM
2.44%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
1,568
New
130
Increased
976
Reduced
425
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$4.92M |
| 2 |
Gilead Sciences
GILD
|
+$4.9M |
| 3 |
AGN
Allergan plc
AGN
|
+$4.71M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.69M |
| 5 |
CELG
Celgene Corp
CELG
|
+$4.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$7.22M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$6.44M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$3.48M |
| 4 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$3.03M |
| 5 |
Procter & Gamble
PG
|
+$2.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.98% |
| 2 | Technology | 14.32% |
| 3 | Consumer Discretionary | 7.2% |
| 4 | Communication Services | 6.5% |
| 5 | Financials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Enviri
NVRI
$621M
| $246K | 0.01% |
14,278
+1,294
| +10% | +$21.3K |
|
1327
Tennant Co
TNC
$1.5B
| $246K | 0.01% |
+3,765
| New | +$251K |
|
1328
Federal Signal
FSS
$7.25B
| $245K | 0.01% |
15,525
+5,122
| +49% | +$79.7K |
|
|
UNT
1329
DELISTED
UNIT Corporation
UNT
| $245K | 0.01% |
8,772
+1,180
| +16% | +$35.1K |
|
|
ROSE
1330
DELISTED
ROSETTA RESOURCES INC
ROSE
| $245K | 0.01% |
14,373
+2,310
| +19% | +$44.2K |
|
|
JBTM
1331
JBT Marel
JBTM
$7.14B
| $244K | 0.01% |
+6,840
| New | +$226K |
|
|
IRBT
1332
DELISTED
iRobot
IRBT
| $243K | 0.01% |
+7,455
| New | +$242K |
|
|
CIM
1333
Chimera Investment
CIM
$1.05B
| $241K | 0.01% |
5,120
-1,143
| -18% | -$54.7K |
|
|
CIVI
1334
DELISTED
Civitas Resources
CIVI
| $241K | 0.01% |
+88
| New | +$252K |
|
1335
Itron
ITRI
$3.73B
| $241K | 0.01% |
6,609
+686
| +12% | +$25.6K |
|
|
DNB
1336
DELISTED
Dun & Bradstreet
DNB
| $241K | 0.01% |
1,879
+24
| +1% | +$3.01K |
|
|
CVGW
1337
DELISTED
Calavo Growers
CVGW
| $240K | 0.01% |
+4,675
| New | +$209K |
|
1338
Allegion
ALLE
$13B
| $239K | 0.01% |
+3,906
| New | +$223K |
|
1339
Hasbro
HAS
$12.6B
| $239K | 0.01% |
3,780
-1,501
| -28% | -$88.1K |
|
1340
HUB Group
HUBG
$3.01B
| $239K | 0.01% |
12,142
+1,588
| +15% | +$29.9K |
|
1341
Navient
NAVI
$774M
| $239K | 0.01% |
11,759
-3,793
| -24% | -$77.9K |
|
1342
TransDigm Group
TDG
$69.2B
| $239K | 0.01% |
+1,093
| New | +$230K |
|
1343
Werner Enterprises
WERN
$2.54B
| $239K | 0.01% |
7,598
+911
| +14% | +$28.1K |
|
1344
HEICO Corp
HEI
$48.9B
| $238K | 0.01% |
+9,529
| New | +$235K |
|
1345
Quanta Services
PWR
$93.9B
| $238K | 0.01% |
8,354
+1,070
| +15% | +$30K |
|
1346
RH
RH
$3.3B
| $238K | 0.01% |
2,397
+311
| +15% | +$28.2K |
|
1347
Unum
UNM
$13.8B
| $238K | 0.01% |
7,052
-2,205
| -24% | -$73.1K |
|
1348
Upbound Group
UPBD
$1.19B
| $238K | 0.01% |
8,659
+903
| +12% | +$27.5K |
|
|
EPAY
1349
DELISTED
Bottomline Technologies Inc
EPAY
| $238K | 0.01% |
+8,685
| New | +$225K |
|
1350
Banco Santander Chile
BSAC
$15.8B
| $237K | 0.01% |
+10,918
| New | +$221K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Profund Advisors held 1,568 positions worth $2.57B, up 5.3% from $2.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Profund Advisors's Q1 2015 filing shows 130 new, 976 increased, 425 reduced and 36 closed positions. Its largest new stake was Qorvo: 54,378 shares worth $4.33M. The largest sale was Allergan Inc, an estimated $7.22M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
- Profund Advisors's largest Q1 2015 buy was Qorvo: 54,378 shares worth $4.33M.
- Profund Advisors added most to Amgen in Q1 2015, an estimated $4.92M increase.
- Profund Advisors's biggest Q1 2015 reduction was Procter & Gamble, cutting an estimated $2.89M.
- Profund Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $7.22M.
- Profund Advisors's ten largest holdings make up 25% of its $2.57B portfolio in Q1 2015.
- Profund Advisors opened 130 new positions and closed 36 in Q1 2015.
- Profund Advisors's portfolio value rose 5.3% quarter-over-quarter to $2.57B.
Based on Profund Advisors's 13F filing for Q1 2015, filed 8 May 2015.